Search research articles
Contact Us
Filters
Showing results (11-20 of 95) with videos related to
Page
of 10
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1997
The role of Raf kinases in development and growth of tumors
U Naumann, I Eisenmann-Tappe, U R Rapp
FEBS Letters
|
September 15, 2001
Diva/Boo is a negative regulator of cell death in human glioma cells
U Naumann, S Weit, J Wischhusen, et al.
Lancet (London, England)
|
July 7, 1999
Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy
F Tergau, U Naumann, W Paulus, et al.
European Journal of Pharmacology
|
October 26, 2000
On the significance of telomerase activity in human malignant glioma cells
M Vietor, S Winter, P Groscurth, et al.
FEBS Letters
|
June 5, 1998
APO2 ligand: a novel lethal weapon against malignant glioma?
J Rieger, U Naumann, T Glaser, et al.
Praxis
|
September 15, 2007
[Iron deficiency anemia in adults. Main symptoms: fatigue, pallor, (stress-) dyspnea, headache, concentration disorders]
P A Krayenbuehl, Kolyvanos U Naumann, L Käser, et al.
Acta Neuropathologica
|
September 25, 2003
Expression and functional activity of osteoprotegerin in human malignant gliomas
U Naumann, W Wick, R Beschorner, et al.
European Journal of Pharmacology
|
February 13, 2001
Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage
F Schmidt, J Rieger, J Wischhusen, et al.
Oncogene
|
November 14, 2003
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death
J Wischhusen, U Naumann, H Ohgaki, et al.
Biochemical and Biophysical Research Communications
|
August 12, 1999
p27 modulates cell cycle progression and chemosensitivity in human malignant glioma
U Naumann, S Weit, L Rieger, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 95) with videos related to
Sort By:
Page
of 10
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1997
The role of Raf kinases in development and growth of tumors
U Naumann, I Eisenmann-Tappe, U R Rapp
FEBS Letters
|
September 15, 2001
Diva/Boo is a negative regulator of cell death in human glioma cells
U Naumann, S Weit, J Wischhusen, et al.
Lancet (London, England)
|
July 7, 1999
Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy
F Tergau, U Naumann, W Paulus, et al.
European Journal of Pharmacology
|
October 26, 2000
On the significance of telomerase activity in human malignant glioma cells
M Vietor, S Winter, P Groscurth, et al.
FEBS Letters
|
June 5, 1998
APO2 ligand: a novel lethal weapon against malignant glioma?
J Rieger, U Naumann, T Glaser, et al.
Praxis
|
September 15, 2007
[Iron deficiency anemia in adults. Main symptoms: fatigue, pallor, (stress-) dyspnea, headache, concentration disorders]
P A Krayenbuehl, Kolyvanos U Naumann, L Käser, et al.
Acta Neuropathologica
|
September 25, 2003
Expression and functional activity of osteoprotegerin in human malignant gliomas
U Naumann, W Wick, R Beschorner, et al.
European Journal of Pharmacology
|
February 13, 2001
Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage
F Schmidt, J Rieger, J Wischhusen, et al.
Oncogene
|
November 14, 2003
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death
J Wischhusen, U Naumann, H Ohgaki, et al.
Biochemical and Biophysical Research Communications
|
August 12, 1999
p27 modulates cell cycle progression and chemosensitivity in human malignant glioma
U Naumann, S Weit, L Rieger, et al.
Page
of 10